By Jeff Siegel
on July 9, 2020
Energy and Capital editor Jeff Siegel is very bullish right now on a small biotech firm that’s currently conducting clinical trials on a new drug that looks like it could not only completely cure chronic diseases, but even reverse them...
By Jeff Siegel
on July 2, 2020
Doctors from biotech firm Verve Therapeutics have developed a new gene-editing serum that switches off the genes that regulate both LDL cholesterol and triglycerides. Energy and Capital editor Jeff Siegel explains how investors can take advantage...
By Jeff Siegel
on June 25, 2020
Energy and Capital editor discusses what black market libraries, PTSD, the opioid crisis, psychedelic mushrooms and investors all have in common. It may be more than you realize...
Oklahoma Dispensaries are Getting Bullied by a Corporate Giant
By Jeff Siegel
on June 22, 2020
Oklahoma Dispensaries are Getting Bullied by a Corporate Giant
By Jeff Siegel
on June 18, 2020
Vikings and psychedelic mushrooms. Energy and Capital editor Jeff Siegel discusses historical instances of psychedelic mushrooms being used by vikings after being inspired by a popular television show to further research the idea...
By Jeff Siegel
on June 4, 2020
As you know, Jeff Siegel helped a lot of Energy and Capital readers make a lot of money in the cannabis space. Not only was it a controversial recommendation, but it was a profitable one. Here is Jeff's next big piece of advice for investors looking for the next big market...
